477 related articles for article (PubMed ID: 8127815)
21. Cortisol-suppressible dexamethasone-nonsuppressible cyclic Cushing's disease with evidence of clinical and biochemical remission with bromocriptine.
Mercado-Asis LB; Murayama M; Yamakita N; Morita H; Mune T; Yasuda K; Miura K
Endocrinol Jpn; 1991 Jun; 38(3):315-24. PubMed ID: 1665413
[TBL] [Abstract][Full Text] [Related]
22. The corticotropin-releasing factor test in the differential diagnosis of Cushing's syndrome: a comparison with the lysine-vasopressin test.
Tabarin A; San Galli F; Dezou S; Leprat F; Corcuff JB; Latapie JL; Guerin J; Roger P
Acta Endocrinol (Copenh); 1990 Sep; 123(3):331-8. PubMed ID: 2239082
[TBL] [Abstract][Full Text] [Related]
23. Clinical experience with a simple screening test for Cushing's syndrome combining the determination of plasma cortisol circadian rhythm with the overnight dexamethasone suppression test.
Reschini E; Giustina G
Am J Med Sci; 1978; 275(1):33-42. PubMed ID: 665710
[TBL] [Abstract][Full Text] [Related]
24. Spot determinations of urinary cortisol for the screening of Cushing's syndrome.
Fujita H; Hata K; Ogata E; Kojima I
Endocrinol Jpn; 1991 Aug; 38(4):441-4. PubMed ID: 1802685
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Cushing's syndrome with the long-acting somatostatin analogue SMS 201-995 (sandostatin).
Invitti C; de Martin M; Brunani A; Piolini M; Cavagnini F
Clin Endocrinol (Oxf); 1990 Mar; 32(3):275-81. PubMed ID: 2160871
[TBL] [Abstract][Full Text] [Related]
26. Problems in the diagnosis of Cushing's syndrome.
Thomson JE; Thomson JA; Beastall GH
Scott Med J; 1977 Apr; 22(2):133-8. PubMed ID: 193180
[TBL] [Abstract][Full Text] [Related]
27. Biochemical evaluation of adrenal dysfunction: the laboratory perspective.
Snow K; Jiang NS; Kao PC; Scheithauer BW
Mayo Clin Proc; 1992 Nov; 67(11):1055-65. PubMed ID: 1331628
[TBL] [Abstract][Full Text] [Related]
28. Cushing's syndrome associated with ectopic production of corticotrophin-releasing hormone, corticotrophin and vasopressin by a phaeochromocytoma.
O'Brien T; Young WF; Davila DG; Scheithauer BW; Kovacs K; Horvath E; Vale W; van Heerden JA
Clin Endocrinol (Oxf); 1992 Nov; 37(5):460-7. PubMed ID: 1283118
[TBL] [Abstract][Full Text] [Related]
29. [Occult bronchial carcinoid tumor producing ACTH simulating Cushing's syndrome].
Herrera Pombo JL; Carrasco Bejar MA; Turbi Disla C; Renedo G
Rev Clin Esp; 1992 Dec; 191(9):485-7. PubMed ID: 1336863
[TBL] [Abstract][Full Text] [Related]
30. Exacerbation of Cushing's syndrome during pregnancy: stimulation of a cortisol-secreting adrenocortical adenoma by ACTH originating from the foeto-placental unit.
St-Jean M; MacKenzie-Feder J; Bourdeau I; Lacroix A
Endocrinol Diabetes Metab Case Rep; 2019 Feb; 2019():. PubMed ID: 30738017
[TBL] [Abstract][Full Text] [Related]
31. [Differential diagnosis of hypothalamic-hypophyseal Cushing's syndrome and ectopic ACTH syndrome (author's transl)].
Kley HK; Betzholz R; Stolze T; Körfer R; Krüskemper HL
Dtsch Med Wochenschr; 1978 May; 103(18):783-6. PubMed ID: 206424
[TBL] [Abstract][Full Text] [Related]
32. Plasma immunoassayable ACTH levels during and after hydrocortisone infusion in patients with Cushing's disease.
Hashimoto K; Takahara J; Hosogi H; Yunoki S; Ofuji T
Endocrinol Jpn; 1976 Jun; 23(3):243-9. PubMed ID: 186258
[TBL] [Abstract][Full Text] [Related]
33. Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome.
Walker BR; Campbell JC; Fraser R; Stewart PM; Edwards CR
Clin Endocrinol (Oxf); 1992 Dec; 37(6):483-92. PubMed ID: 1337504
[TBL] [Abstract][Full Text] [Related]
34. [A case of Cushing's disease associated with a non-functioning adrenal tumor].
Ohguni S; Takagi C; Masaki Y; Notsu K; Hori T; Kato Y
Nihon Naibunpi Gakkai Zasshi; 1992 Dec; 68(12):1249-56. PubMed ID: 1291336
[TBL] [Abstract][Full Text] [Related]
35. Reply to the letter to the editor from Piazzola and Castinetti: "Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH dependent Cushing's syndrome: results from a retrospective multicenter study".
Detomas M; Deutschbein T
Eur J Endocrinol; 2023 Dec; 189(6):R17-R18. PubMed ID: 37956461
[No Abstract] [Full Text] [Related]
36. Plasma cortisol profiles in Cushing's syndrome.
Yoshida K; Satowa H; Sato A; Ichikawa Y; Kream J; Levin J; Zumoff B; Hellman L; Fukushima DK
Acta Endocrinol (Copenh); 1979 Jun; 91(2):319-28. PubMed ID: 223357
[TBL] [Abstract][Full Text] [Related]
37. Single-dose four hour dexamethasone suppression test in normal men and its application for the diagnosis of Cushing's syndrome.
Nishida S; Matsumura S; Horino M; Oyama H; Tenku A
Steroids; 1976 Sep; 28(3):411-21. PubMed ID: 982498
[TBL] [Abstract][Full Text] [Related]
38. The overnight dexamethasone test is a worthwhile screening procedure.
Cronin C; Igoe D; Duffy MJ; Cunningham SK; McKenna TJ
Clin Endocrinol (Oxf); 1990 Jul; 33(1):27-33. PubMed ID: 2401096
[TBL] [Abstract][Full Text] [Related]
39. Comparative value of plasma ACTH and beta-endorphin measurement with three different commercial kits for the etiological diagnosis of ACTH-dependent Cushing's syndrome.
Tabarin A; Corcuff JB; Rashedi M; Navarranne A; Ducassou D; Roger P
Acta Endocrinol (Copenh); 1992 Apr; 126(4):308-14. PubMed ID: 1317630
[TBL] [Abstract][Full Text] [Related]
40. Recurrent Cushing's disease with low adrenal androgen production.
Louard RJ; Gelfand RA
J Endocrinol Invest; 1991 Dec; 14(11):965-9. PubMed ID: 1666899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
